Candel Therapeutics Inc
Biotechnology
Healthcare
CADL
32.01 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
4.33
52 week high
12.21
high
5.13
52 week low
3.80
previous Close
4.40
P/E ratio
market cap
134 M
div yield
0
net incoming
-10.65 M
52.12 %
net profit margin
-1064600000.00 %
0.00 %
operating incoming
-8.76 M
-2.17 %
net change in cash
-4.63 M
-8.71 %
cash on hand
16.56 M
-22.82 %
top